News Sigrid Therapeutics raises funding of $8.4M This financing round was raised from US, Irish and Swedish investors alongside a large-scale industrial…SanaNovember 10, 2021
News Unique Swedish concept for two of the world’s biggest health challenges closer to breakthrough Swedish Sigrid Therapeutics, which has developed a unique concept to prevent two of the world's…SanaNovember 8, 2021
News Sigrid Profiled in SvD, Sweden’s Largest Daily Magazine We are happy to have been profiled in SvD, Sweden's largest daily magazine. Read more…SanaNovember 3, 2021
News Former President of Eli Lilly Research Labs and Head of R&D Dr. Jan Lundberg invests in Sigrid Therapeutics and joins the Company’s Scientific Advisory Board Breakthrough SiPore15TM silica particle-based diabetes and obesity treatment on track for commercial material scale up…Liu MingJune 2, 2020
News Sana Alajmovic: ”Vi måste tala om de stora visionerna – bygga nästa Astra” Life Science Sweden BenMay 12, 2020
News Major Swedish study provides additional proof of concept for Sigrid’s medical device SiPore15 for preventing diabetes and treating obesity Tiny mesoporous silica particles block food enzymes reducing metabolic risk factors and blood sugar levels…Liu MingMay 4, 2020
Hiring Summer internship position at Sigrid Therapeutics ARE YOU OUR NEXT SUMMER INTERN? Summer internship position at Sigrid Therapeutics Sigrid Therapeutics (Sigrid)…Liu MingApril 23, 2020
News The Stockholm Material Hub, of which Sigrid Therapeutics is a long-term collaborator of, receives €0.5 M boost from European Regional Development Fund Sigrid Therapeutics today announced that the Stockholm Material Hub, a long-term collaboration partner of the…Liu MingMarch 25, 2020
News Stockholm Material Hub, vilken Sigrid Therapeutics är en nyckelpartner till, erhåller €0,5 miljoner i bidrag från Europeiska Regionala Utvecklingsfonden Sigrid Therapeutics meddelade idag att Stockholm Material Hub, företagets samarbetspartner sedan länge, har säkrat €0,5 miljoner…Liu MingMarch 25, 2020